by activating cell membrane receptors with tyrosine kinase activity (RTKs) or, less frequently, receptors with serine/threonine kinase activity. The mechanism of RTK activation following binding of a growth factor is dimerization and autophosphorylation of tyrosine residues which induces the receptor to trigger the activation of mitogenactivated protein kinases or MAPKs (see Schlessinger, 2000 , for review). There are three well-known groups of MAPKs: extracellular signal-regulated kinases (ERKs), c-Jun amino-terminal kinases (JNKs), and p38 kinases (see Johnson and Lapadat, 2002, for review) . These are highly conserved enzymes that share the common property of being activated by three-tier phosphorylation cascades in response to a variety of stimuli. The ERK pathway is preferentially stimulated by growth factors and phorbol esters whereas the JNK and p38 pathways are usually activated by ionizing radiation, osmotic shock and other stress stimuli.
RTK stimulation by growth factors is usually associated with activation of ERK's, in particular ERK1 and ERK2. These are highly similar serine/threonine kinases, 44 and 42 kDa, respectively, that are themselves activated by double phosphorylation on tyrosine and threonine residues. The most important intracellular signaling cascade for ERK activation involves the activation of Ras, a membrane-bound GTP-binding protein (see Fig. 1 ). Similar to other GTP binding proteins, Ras is activated by exchanging its bound GDP for GTP. This initiates a cascade of intracellular phosphorylation events in which upstream kinases phosporylate, i.e. activate, downstream kinases according to the following sequence: Raf (also known as MEK Kinase, MEKK, or MAPKKK), MEK (or MAPKK kinase) and ERK (also referred to as MAPK; see Wilkinson and Millar, 2000, for review). A host of tissue-specific adapters and scaffolds are also required for the activation of this cascade which will not be discussed here because they are beyond the scope of this review (see Roux and Blenis, 2004, for review) . Phosphorylated ERK's play a central role in growth factor signaling because they phosphorylate a variety of membrane and cytoskeletal proteins, downstream kinases and, most importantly, transcription factors, such as Elk-1 and the proto-oncogen product c-myc, that ultimately mediate specific cell responses (see Schaeffer and Weber, 1999, for review) .
GROWTH FACTORS AND THE EPIDIDYMIS
In recent years a number of investigators have explored the role of growth factors in the physiology of the epididymis and the male reproductive system in general.
Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF) and basic
Fibroblast Growth Factor (bFGF) have received the most attention but other growth factors have been studied as well, and a concise review seems appropriate at this time when more rapid advances are being made in the field. We have also included here references to research demonstrating the presence of growth factors in the testis, given the fact that substances secreted by the testis may influence the epididymis in a lumicrine fashion. Finally, we illustrate mRNA expression data for selected growth factors and growth factor receptors from a recently published database, the mouse epididymal transcriptome (MET), detailing gene expression of all mouse epididymal segments . In this study, a collaboration between our and other laboratories, mRNA expression in all 10 segments of the mouse epididymis was analyzed using Affimetrix gene chips (see Fig. 2 ). The MET database is available online at www.mrg.genetics.washington.edu.
Epidermal Growth Factor
An early indication of a potential role for EGF in the male reproductive system was the observation that the removal of the submaxillar gland ─an organ rich in EGF─ led to a marked decrease of epididymal sperm cells in adult mice without affecting the levels of testosterone or follicle-stimulating hormone (Tsutsumi et al., 1986) . Moreover, changes were reversed by administration of EGF confirming that they were caused by EGF deprivation. It has been reported however that this effect is much smaller than originally claimed (Russell et al., 1990) . EGF is a 53 amino acid, 6 kDa protein that was originally discovered as a result of the observation that mice submaxillary gland extracts accelerate the development of newborn animals (Cohen, 1962; Carpenter and Cohen, 1990) . Over the years, EGF has proven to be a growth factor that stimulates not only the proliferation of epithelial cells but also a host of other cell types of both ectodermic and mesodermic origin. The effect of EGF on spermatogenesis prompted studies that have demonstrated the presence of both EGF (Byyny et al., 1972; Elson et al., 1984) and EGF receptors (Suarez-Quian et al., 1989; Suarez-Quian and Niklinski, 1990; Foresta et al., 1991) in the testes of different species including humans, mice and rats. Moreover, studies in mice have demonstrated the ability of testicular extracts to displace 125 I-EGF from its receptor in a manner indistinguishable from that of submaxillary gland extracts, which suggests the presence of the canonical, 6 kDa form of EGF in the testis . Studies on non-human primates confirmed the presence of the EGF receptor in the testis and demonstrated that this receptor is also present in the epididymis and the vas deferens . The EGF receptor (EGFR) is located in both the basolateral and apical borders of epididymal epithelial cells. Moreover, the luminal staining showed vesicular images consistent with a pattern of receptor-mediated endocytosis. Further immunohistochemical studies on C3H mice (Suarez-Quian et al., 1994) showed that the intracellular localization of the EGF receptor varies along the length of the epididymis: in the caput staining was intense and evenly distributed in the cytoplasm of principal cells whereas in the corpus and cauda staining was limited to the apical cytoplasm.
The presence of a growth factor in a tissue does not necessarily mean that it is synthesized there. Other investigations have shown that the testis is, in fact, a source of EGF . In these studies the presence of the intracellular EGF precursor (EGF p ) in the mouse testis was investigated by Western blotting and immunohistochemistry. EGF p is a 140 kDa integral membrane protein from which the 6 kDa, active EGF is released by proteolytic cleavage and whose presence in a given tissue strongly suggest that EGF is locally synthesized. In contrast to EGF, which was found to be widely distributed in the testis including Sertoli cells, EGF p was restricted to germ cells suggesting a paracrine signaling mechanism. The presence in the testis of EGF, usually a paracrine-acting growth factor, is important for epididymal physiology given the potential lumicrine influence of testicular factors on the epididymis (Fawcett and Hoffer, 1979; Nicander et al., 1983 .
Aside from a single report of putative EGF in the human epididymis (Elson et al., 1984) , the actual presence of EGF in the epididymis has not been determined. In this regard, it is interesting that data from MET database demonstrates that the Egf gene is expressed in the epididymis in a segment-specific manner (Fig. 2) . Thus, it is possible that in addition to the lumicrine model, cells of the epididymal interstitium, e.g. macrophages, fibroblasts, synthesize and secrete EGF for communication to cells in the adjacent tubule epithelium.
Interestingly, expression of the Egf gene is relatively low in the most proximal segments of the caput epididymis, but rises approximately 4 fold by segment 7, which comprises most of the corpus region. In this part of the duct, any EGF from the testis may no longer be available to the epithelium, and it can be hypothesized that the epithelial cells may depend more on local, paracrine-acting EGF. EGF receptor gene expression reported in the MET database is relatively constant throughout the epididymis (Fig.2) ; thus, if the epididymal expression of Egf and Egfr are confirmed by protein presence, the data will be consistent with the concept that lumicrine EGF is important in the proximal caput of the mouse epididymis and paracrine EGF is more important in more distal segments, especially in the corpus epididymis. Whether such an hypothesis is true in the mouse or other species is yet to be determined, but these initial gene expression data do offer the possibility that EGF plays a meaningful role in the segmental regulation of the epididymal tubule.
Of note, the MET database shows that Cd97, a member of the EGF seven-span transmembrane receptor family, is up to 10-fold more highly expressed than Egfr in the mouse epididymis, especially in the cauda segments (not shown). CD97 has an extended extracellular region with several N-terminal EGF-like domains which mediate binding to its ligand (Jaspers et al., 2001 ). CD97's role in cell signaling in macrophages and dendritic cells has previously been studied, and it will be interesting to determine if these cells are playing a regulatory role within the segment(s) in which they reside. -releasing effect of IP3 on intracellular Ca 2+ stores.
Fibroblast Growth Factors
The first FGF was discovered as a compound that stimulates the proliferation of NIH3T3 cells (Gospodarowicz and Moran, 1975) . It was later dubbed "basic" to be distinguished from acidic FGF extracted from the bovine brain. Similar to EGF, basic FGF (bFGF) has been shown to be present in the testis (Ueno et al., 1987; Mayerhofer et al., 1991; Han et al., 1993) . Additional studies have shown that the ovine rete testis fluid contains a factor that stimulates the growth of fibroblasts (Brown et al., 1982) and that homogenates of bovine and human epididymides exhibit bFGF-like activity (Story et al., 1988) . The MET data suggest differential expression of both Fgf and Fgfrs along the length of the epididymis. The two most highly expressed FGF genes, Fgf7 and Fgf12,
show differential pattern of expression, with Fgf12 being more highly expressed in caput segments and Fgf7 peaking in segment 9 of the cauda (Fig. 3) .
Among the FGFR genes
Fgfr4 is the most abundant by far and peaks in the cauda epididymis (Fig. 4) .
Although the biological relevance of these findings in not yet understood, results
by Hinton et al. (2003) suggest a lumicrine mode of action for FGF. Hinton and associates investigated the influence of bFGF on the activity of epididymal gammaglutamyl transpeptidase (GGT) after efferent duct ligation, which deprives the epididymal lumen of testicular factors . GGT is believed to help protect sperm cells from oxidative stress by maintaining adequate levels of glutathione which prevents the oxidation of protein thiols to disulfides. Lan et al. (1998) showed that bFGF treatment restores the reduced levels of GGT and GGT activity that are observed in the initial segment of the rat epididymis after efferent duct ligation and concluded that low GGT activity after efferent duct ligation reflects the absence of stimulation by a testicular factor or factors. Interestingly, GGT activity can be restored with rete testis fluid but not with EGF. Taken together, these experiments provide an example of the regulation of an important epididymal function by testicular factors and point to bFGF as a likely mediator. In a related study the presence of FGFRs was investigated in cells of the initial segment of the rat epididymis by RT-PCR and immunoblotting . All four types of FGFRs were found to be expressed in the rat initial segment with principal cells only expressing FGFR-1 (splice variant IIIc). Once again, these results support the notion of a trophic influence of the testicle on the epididymis.
Vascular Endothelial Growth Factor
Vascular Endothelial Growth Factor (VEFG) was initially characterized as a factor that increases the permeability of tumor blood vessels (Senger et al., 1983) and subsequently found to be a potent mitogen specific for vascular endothelial cells (Leung et al., 1989; Keck et al., 1989) . VEGF plays a key role in angiogenesis during Staining for Flt-1 in the human epididymis was mostly negative with the exception of some reactivity in interstitial lymphatic vessels but it was very strong in basal and ciliated cells of the distal part of the efferent ducts.
In the mouse, Flt-1 has been detected by in situ hybridization in endothelial cells of interstitial blood vessels throughout the epididymis (Korpelainen et al., 1998) . Finally, electron microscopy examination of human epididymides treated topically with VEGF has shown an increased number of fenestrated capillaries, opened tight junctions, and intracellular vesicles which suggests the possibility that several aspects of epididymal biology may be influenced by VEGF via activation of the VEGF receptor.
A potential role of VEGF in the reproductive system of the mouse has been explored in transgenic mice expressing VEGF under the mouse mammary tumor virus LTR promoter (Korpelainen et al., 1998) . These mice show aberrant spermatogenesis and a malformed epididymis and, as a consequence, are not fertile. The epididymides of these animals are enlarged and swollen. Histological examination shows, among other changes, that the epithelium in the caput epididymis is reduced in height as compared to wild type controls whereas the cauda shows an hyperplastic epithelium. These characteristics are typical of those seen with a chronic, proximal duct obstruction, though this has not been verified in this case. Interestingly, the areas of epithelial hyperproliferation exhibited higher expression of both VEGF and VEGFR as well as an increased number of blood vessels and increased capillary permeability (Korpelainen et al., 1998) . Whether this reflects on the role of VEGF in the epididymis or merely upon a related aspect of the phenotype remains unknown.
Immunohistochemical studies using an antibody directed against the amino terminal portion of VEGF show that VEGF immunoreactivity in the testes is localized to Leydig and Sertoli cells (Ergün et al., 1997) . Secretion from Sertoli cells could potentially reach the epididymis via the lumicrine route and influence the activity of the epididymal epithelium. This would be consistent with the existing evidence that testicular factors, potentially VEGF among them, play an important role in the physiology of the epididymis. Alternatively, it may be the case that VEGF could be playing a paracrine role in the early segments of the mouse epididymis since VEGF expression is relatively high in this region (Fig. 5) , this would be consistent with the studies by Ergün et al. (1998) showing immunolocalization of VEGF to cells in the human epididymal interstitial compartment, including macrophages.
Other Growth Factors
Nerve growth factor (NGF) is a disulfide-linked homodimer of two 13.5 kDa monomers that plays a central role in the development of sympathetic neurons and also promotes growth and differentiation (see Chao, 2003, for review) . It is also known as β- (Okamura et al., 1995) , that PDGF may be involved in the regulation of the secretion of this and perhaps other proteins by the epithelium of the epididymis.
The transforming growth factor-β (TGF-β) family comprises three 25 kDa isoforms of TGF-β (β1, β2, and β3). They are secreted by certain tumor and normal cells and are capable of transforming non-tumoral cells in culture. They have been shown to influence various morphogenetic processes such as growth, differentiation, wound healing and apoptosis (see Shi and Massagué, 2003, for review) . It is known that TGF-β is present in the testis (Caussanel et al., 1997) and influences both Leydig (Morera et al., of TGF-β in the epididymis.
It has been recently demonstrated by immunohistochemistry that TGF-β1 and the TGF-β receptor type II are both present in the epithelial cells of the caput and corpus regions of the epididymis of the marmoset monkey (Bomgardner et al., 1999) . Whereas TGF-β1 was localized to apical cells, the TGF-β receptor type II was restricted to principal cells; but in both cases, a higher proportion of stained cells was observed in the caput than in other regions. Studies by RT-PCR confirmed TGF-β1 expression in the epididymis (Bomgardner et al., 1999) . These observations prompted the hypothesis that TGF-β may have a paracrine role in the epididymis, possibly in relation to the effects of dihydrotestosterone and estrogens. Similar studies in the rat epididymis have shown that TGF-β1 localization is mostly interstitial rather than epithelial but failed to show any regional distribution. TGF-β3 localization, on the other hand, is epithelial and almost exclusively restricted to the corpus (Desai et al., 1998) . Additional analysis by Northern blotting confirmed these results and showed that the expression of TGF-β3 mRNA in the corpus is sixfold higher than in the caput and cauda. Studies in castrated rats (Desai and Kondaiah, 2000) also support the notion of a interaction between androgens and TGF-β.
In these animals, TGF-β1 mRNA expression as detected by Northern blotting increases dramatically in the corpus, approximately tenfold relative to noncastrated animals, and somewhat less, three to fourfold, in the caput and cauda. Most important, these changes are reversed by testoterone treatment. TGF-β2, normally undetectable, is upregulated except in the cauda, and TGF-β3 increases in the caput, much less in the corpus but not in the cauda. In the mouse, according to the MET database, the gene for TGF-β1 is the form most prominently expressed especially in segment 1.
The presence of insulin-like growth factor (IGF) in the epididymis was originally reported by Hanson et al. (1988) . Insulin-like growth factors I (originally named somatomedin C) and II are small proteins (~ 22 kDa) structurally related to proinsulin that play important endocrine, paracrine and autocrine roles in normal, tumoral and developing tissues (see Grimberg and Cohen, 2000 , for review). These biological effects are regulated by IGF binding proteins (IGFBPs) that limit the bioavailability of IGFs and, in some cases, behave as IGF antagonists. A detailed study by immunohistochemistry of the distribution of IGF I in the rat epididymis (Leheup and Grignon, 1993) has shown that at early postnatal ages (2 to 4 weeks) immunostaining is localized to epithelial cells. At later ages (4 to 8 weeks) immunostaining, particularly in the cauda, is less prominent in the epithelium and more intense in myofibroblastic cells. Neither IGF nor IGFBPs gene expression are above background in the adult mouse epididymis as detected in the MET database. Studies on the distribution of a IGFBP-rP1, however, show that this protein is present in the epithelium of the human epididymis (Degeorges et al., 2000) . The significance of these results is unknown, but it is possible that in some species IGF I may have a role in the epididymis.
It has recently been reported that erythropoietin (Epo) is produced by the mouse epididymis (Kobayashi et al., 2002) . RT-PCR shows that the epididymis expresses Epo mRNA at relatively high levels, approximately 40% of the levels observed in the kidney.
Secretion of Epo was confirmed by incubating epididymal tissue for 2 to 8 h in presence and absence of the protein synthesis inhibitor cycloheximide. Levels of Epo in the culture medium, as revealed by ELISA, were greatly reduced by this drug. Interestingly, Epo production was testosterone-and estradiol-independent. In situ hybridization analysis shows that Epo is likely to be produced by interstitial cells. Epo is a 34 kDa glycoprotein secreted by the fetal liver and the adult kidney that is essential for erithropoiesis by stimulating bone marrow erythroid progenitors to proliferate and differentiate (see Jelkmann, 1992, for review) . Although the kidney is the most important source of Epo in adulthood, other tissues, such as the brain and female reproductive organs, are also sources of Epo (see Ebert and Bunn, 1999, for review) . Interestingly, the temporal pattern of Epo secretion by the epididymis resembles that of the kidney: an initial peak followed by a phase of downregulation, which contrasts with the response of other organs that exhibit a more sustained secretory response (Kobayashi et al., 2002) . Accordingly, it has been speculated that the epididymis may be a source of circulating Epo (Kobayashi et al., 2002) . This notion has recently been supported by the demonstration of the presence of hypoxia-inducible factor-1 (HIF-1) in the rat epididymis (Palladino et al., 2004) which is a transcription factor that activates several genes involved in oxygen homeostasis, including Epo. The gene for Epo is not represented in the MET database, but Epo receptor is expressed in all 10 epididymal segments (not shown).
Finally, it has been suggested that Hepatocyte Growth Factor (HGF) may be a mediator of the increased motility attained by sperm cells during epididymal transit. HGF is a potent angiogenic and tumor-promoting substance found in a variety of tissues (see Jiang et al., 2005, for review) . Experiments in rats show that as sperm cells move from the caput to the cauda epididymis, they show a more widespread distribution of c-met, a receptor for HGF (Catizone et al., 2002) . This has been correlated with previous observations in mice showing that HGF can be detected by immunohistochemistry in the mouse distal corpus and cauda but not the caput and the fact that HGF initiates motility of caput, but not cauda, epididymis sperm cells (Naz et al., 1994) . Moreover, Catizone et al., 1994 , have shown that the motility of rat caput sperm cells is maintained in vitro by the presence of HGF. These investigators believe that HGF may be important in the acquisition of sperm cell motility in the epididymis because these cells are exposed to higher concentrations of HGF as they move to the cauda and, in addition, they may be more sensitive to this substance because of the increase in c-met. The fact that sperm cells are immotile in situ in the cauda epididymis of most species studied (Turner and Reich, 1985; Turner et al., 2005) suggest that this relationship is of a more complex nature.
CONCLUDING REMARKS
The studies reviewed here have contributed to a body of information related to possible roles of growth factors in the epididymis. They are valuable in that they have revealed the presence and distribution of different growth factors in the epididymis of different species and pointed out potential biological roles for these substances.
Unfortunately, for the most part these studies have not gone far beyond that. Moreover,
given the scatter of the data across different species and growth factors and the fact that multiple studies were rarely focused on a single theme, it has not been possible to envision a unified theory accounting for the bulk of observations reported. A consistent data pattern has not emerged, and in many cases it is not clear that observations in one species can be extrapolated to another. Obviously, the role of growth factors in the epididymis cannot be ascertained from localization studies alone. Rather, more mechanistic and functional studies like those provided by Ergün et al. (1998) and Hinton and colleagues are required.
In this connection, an important aspect of the biology of growth factors remains mostly unexplored: what are the intracellular signaling cascades activated by growth factors in the normal and diseased epididymis? Although, we know, for example, that the members of the raf and myc gene families are expressed in the mouse epididymis (Winer et al., 1993; Cornwall et al., 2001) , much more information about these and other intracellular mediators is going to be required to understand the biological role of growth factors on the epididymis.
Our current understanding of the physiology of the epididymis indicates that the epididymal tubule is regulated within segments (Turner et al., 2003; Johnston et al., 2005) , therefore future investigations can be envisaged which study the role of growth factors within those separate segments. For instance, are there sharp differences in how different segments respond to paracrine or lumicrine factors? In the above mentioned cases about the raf and myc genes, it has been already demonstrated that A-raf and Bmyc expression shows a segment-specific pattern and depends on androgens and testicular factors (Winer and Wolgemuth, 1995; Cornwall et al., 2001) . It is also likely that the idiosyncratic nature of ERK activation may play a role in the biology of the epididymis. As previously mentioned, ERK activation is a complicated phenomenon requiring specific temporal and spatial arrangements of kinases and other molecules (see Schaeffer and Weber, 1999 for review) and, often, cross-talk with other signaling systems such as Ca 2+ -regulated cascades (Agell et al., 2002) .
While further investigations are needed to understand the role of growth factors in the epididymis, the work already done has helped to delineate possible avenues for further research. On the one hand, a great deal of circumstantial evidence has been provided supporting the notion that growth factors play a role in epididymal physiology.
These leads should be pursued emphasizing the functional aspects of growth factors, at the cellular and subcellular levels. On the other hand, the concept of epididymal segmentation provides a useful paradigm to further refine our understanding of this organ. As the mouse epididymal transcriptome substantiates, epididymal segments, either alone or in concert with adjacent segments, form functional units exhibiting unique patterns of gene expression and are likely to be differentially influenced by selected growth factors. The convergence of these two approaches may prove to be effective for further defining the biological role of growth factors on the epididymis and, ultimately, for increasing our understanding of the ability of the epididymis to promote sperm maturation. Expression data was obtained from a microarray analysis originally performed by our laboratory . Briefly, epididymides were obtained from anesthetized C57BL/6 mice and segments immediately dissected. Similar segments from five animals were pooled and mRNA was obtained using standard phenol/guanidine isothiocyanate extraction. mRNA was then used as a template to generate biotin-labeled cRNA. Gene 
